Schizophrenia candidate gene ERBB4: Covert routes of vulnerability to psychosis detected at the population level

Schizophrenia Bulletin

Volumn 39, Issue 2, 2013, Pages 349-357

  Stefanis, Nicholas C ^a,b,c   Hatzimanolis, Alex ^b   Smyrnis, Nikolaos ^b   Avramopoulos, Dimitrios ^d   Evdokimidis, Ioannis ^a   Van Os, Jim ^e   Stefanis, Costas N ^a   Straub, Richard E ^f   Weinberger, Daniel R ^f  

^a UNIVERSITY MENTAL HEALTH RESEARCH INSTITUTE   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

polymorphism; psychotic symptoms; schizophrenia; schizotypy; stress; working memory

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ADULT; ARTICLE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; MALE; MARKER GENE; MENTAL STRESS; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VERBAL WORKING MEMORY; WORKING MEMORY;

ADOLESCENT; CROSS-SECTIONAL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MILITARY PERSONNEL; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; YOUNG ADULT;

EID: 84874546200     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbr169     Document Type: Article

References (40)

1. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002;71:877-892. (Pubitemid 135750519)
2. Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 2008;9:437-452. (Pubitemid 351704944)
3. Nicodemus KK, Law AJ, Radulescu E, et al. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch Gen Psychiatry. 2010;67:991-1001.
4. Gerlai R, Pisacane P, Erickson S. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res. 2000;109:219-227. (Pubitemid 30179672)
5. Walsh T, McClellan JM, McCarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539-543. (Pubitemid 351590668)
6. Norton N, Moskvina V, Morris DW, et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2006;141:96-101. (Pubitemid 43062550)
7. Shiota S, Tochigi M, Shimada H, et al. Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population. J Hum Genet. 2008;53:929-935.
8. Benzel I, Bansal A, Browning BL, et al. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct. 2007;3:31.
9. Nicodemus KK, Luna A, Vakkalanka R, et al. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry. 2006;11:1062-1065. (Pubitemid 44863428)
10. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet. 2006;141:142-148. (Pubitemid 43214789)
11. Law AJ, Kleinman JE, Weinberger DR, Weickert CS. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet. 2007;16:129-141. (Pubitemid 46178996)
12. Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res. 2008;100:270-280.
13. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005;10:40-68. (Pubitemid 40139588)
14. Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 2004;27:683-690. (Pubitemid 39335839)
15. Konrad A, Vucurevic G, Musso F, Stoeter P, Dahmen N, Winterer G. ErbB4 genotype predicts left frontotemporal structural connectivity in human brain. Neuropsychopharmacology. 2009;34:641-650.
16. Stefanis NC, Trikalinos TA, Avramopoulos D, et al. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry. 2007;62:784-792. (Pubitemid 47374644)
17. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis pronenesspersistence-impairment model of psychotic disorder. Psychol Med. 2009;39:179-195.
18. Kelleher I, Cannon M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol Med. 2011;41:1-6.
19. Tomppo L, Hennah W, Miettunen J, et al. Association of variants in DISC1 with psychosis-related traits in a large population cohort. Arch Gen Psychiatry. 2009;66:134-141.
20. Cougnard A, Marcelis M, Myin-Germeys I, et al. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med. 2007;37:513-527. (Pubitemid 46359599)
21. Lataster T, Myin-Germeys I, Derom C, Thiery E, van Os J. Evidence that self-reported psychotic experiences represent the transitory developmental expression of genetic liability to psychosis in the general population. Am J Med Genet B Neuropsychiatr Genet. 2009;150:1078-1084.
22. van Winkel R, Stefanis NC, Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull. 2008;34:1095-1105.
23. Johns LC, Cannon M, Singleton N, et al. Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry. 2004;185:298-305. (Pubitemid 39331331)
24. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry. 2006;188:519-526. (Pubitemid 43844098)
25. Steinberg HR, Durell J. A stressful social situation as a precipitant of schizophrenic symptoms: an epidemiological study. Br J Psychiatry. 1968;114:1097-1105.
26. Stefanis NC, Henquet C, Avramopoulos D, et al. COMT Val158Met moderation of stress-induced psychosis. Psychol Med. 2007;37:1651-1656. (Pubitemid 47606851)
27. Smyrnis N, Kattoulas E, Stefanis NC, Avramopoulos D, Stefanis CN, Evdokimidis I. Schizophrenia-related Neuregulin-1 single-nucleotide polymorphisms lead to deficient smooth eye pursuit in a large sample of young men. Schizophr Bull. December 4, 2009; doi:10.1093/schbul/sbp150.
28. Stefanis NC, Smyrnis N, Avramopoulos D, Evdokimidis I, Ntzoufras I, Stefanis CN. Factorial composition of self-rated schizotypal traits among young males undergoing military training. Schizophr Bull. 2004;30:335-350. (Pubitemid 38828540)
29. StefanisNC,Vitoratou S,Ntzoufras I, SmyrnisN,Evdokimidis I, StefanisCN. Psychometric properties of theGreek version of the Schizotypal Personality Questionnaire (SPQ) in young male obligatory conscripts: A two years test-retest study. Pers Individ Dif. 2006;41:1275-1286. (Pubitemid 44348541)
30. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull. 1991;17:555-564.
31. Derogatis R. Symptom Checklist-90-R (SCL-90-R). Minneapolis, MN: Computer Systems; 1993.
32. Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005;330:11.
33. Rossler W, Riecher-Rossler A, Angst J, et al. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res. 2007;92:1-14. (Pubitemid 46561217)
34. Dominguez MD, Wichers M, Lieb R, Wittchen HU, van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull. 2011;37:84-93.
35. Smyrnis N, Avramopoulos D, Evdokimidis I, Stefanis CN, Tsekou H, Stefanis NC. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men. Biol Psychiatry. 2007;61:845-853. (Pubitemid 46412273)
36. Fazzari P, Paternain AV, Valiente M, et al. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature. 2010;464:1376-1380.
37. Avramopoulos D, Stefanis NC, Hantoumi I, Smyrnis N, Evdokimidis I, Stefanis CN. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry. 2002;7:706-711. (Pubitemid 34984947)
38. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265. (Pubitemid 40202029)
39. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008;66:87-98. (Pubitemid 351482562)
40. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978-989. (Pubitemid 32289743)